Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2018 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2018 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21

  • Authors:
    • Yaochen Cao
    • Jialin Hu
    • Jianying Sui
    • Limei Jiang
    • Yakun Cong
    • Guoqing Ren
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, Daqingshi No. 4 Hospital, Daqing, Heilongjiang 163712, P.R. China
    Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2442-2448
    |
    Published online on: July 20, 2018
       https://doi.org/10.3892/etm.2018.6489
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Patients with chronic kidney disease (CKD) are characterized by a gradual loss of kidney function over time. A number of studies have indicated that tubule interstitial fibrosis (TIF) is associated with the occurrence and development of CKD. The aim of the present study was to investigate the effect of quercetin treatment on the fibrosis of renal tubular epithelial cells and to determine whether the anti‑fibrotic effects of quercetin are achieved via microRNA (miR)‑21. Human tubular epithelial HK‑2 cells were cultured with transforming growth factor (TGF)‑β to induce fibrosis and the expression of fibrotic markers collagen I, fibronectin, α‑smooth muscle actin (SMA) and epithelial‑cadherin were measured using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting. Cells were treated with 7.5, 15 or 30 mg/ml quercetin, following which fibrosis and miR‑21 expression were evaluated. Quercetin‑treated cells were transfected with miR‑21 mimics and the expression of fibrotic markers was examined using RT‑qPCR. Finally, the expression of fibrosis‑associated miR‑21 target genes, phosphatase and tensin homolog (PTEN) and TIMP Metallopeptidase Inhibitor 3 (TIMP3), was measured in cells treated with quercetin with or without miR‑21 mimics using RT‑qPCR, western blotting and immunocytochemistry. The results revealed that TGF‑β treatment induced a significant increase in the expression of fibrotic markers in HK‑2 cells, while quercetin treatment partially inhibited the fibrosis of HK‑2 cells. Furthermore, quercetin treatment significantly inhibited TGF‑β‑induced miR‑21 upregulation and transfection with miR‑21 mimics reversed the anti‑fibrotic effects of quercetin. Quercetin treatment markedly upregulated PTEN and TIMP3 expression, whereas transfection with miR‑21 mimics reversed this effect. The results of the present study suggest that quercetin is able to alleviate TGF‑β‑induced fibrosis in HK‑2 cells via suppressing the miR‑21 and upregulating PTEN and TIMP3. Quercetin may have potential as an anti‑fibrotic treatment for patients with renal fibrosis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Zhou D, Fu H, Zhang L, Zhang K, Min Y, Xiao L, Lin L, Bastacky SI and Liu Y: Tubule-derived wnts are required for fibroblast activation and kidney fibrosis. J Am Soc Nephrol. 28:2322–2336. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Omata M, Doke Y, Yamada C, Kawashima K, Sho R, Enomoto K, Furuya M and Inomata N: Hepatocyte nuclear factor-1β induces redifferentiation of dedifferentiated tubular epithelial cells. PLoS One. 11:e01549122016. View Article : Google Scholar : PubMed/NCBI

3 

Lu H, Chen B, Hong W, Liang Y and Bai Y: transforming growth factor-β1 stimulates hedgehog signaling to promote epithelial-mesenchymal transition after kidney injury. FEBS J. 283:3771–3790. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Chen SJ, Wu P, Sun LJ, Zhou B, Niu W, Liu S, Lin FJ and Jiang GR: miR-204 regulates epithelial-mesenchymal transition by targeting SP1 in the tubular epithelial cells after acute kidney injury induced by ischemia-reperfusion. Oncol Rep. 37:1148–1158. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Jara P, Calyeca J, Romero Y, Plácido L, Yu G, Kaminski N, Maldonado V, Cisneros J, Selman M and Pardo A: Matrix metalloproteinase (MMP)-19-deficient fibroblasts display a profibrotic phenotype. Am J Physiol Lung Cell Mol Physiol. 308:L511–L522. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Meng XM, Zhang Y, Huang XR, Ren GL, Li J and Lan HY: Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin. Oncotarget. 6:36984–36997. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Muñoz-Félix JM, González-Núñez M, Martínez-Salgado C and López-Novoa JM: TGF-U/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations? Pharmacol Ther. 156:44–58. 2015.PubMed/NCBI

8 

Vega G, Alarcón S and San Martin R: The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis. Cytokine. 88:115–125. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Garzon R, Calin GA and Groce CM: MicroRNAs in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Han F, Konkalmatt P, Chen J, Gildea J, Felder RA, Jose PA and Armando I: miR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells. Hypertension. 65:1118–1125. 2015. View Article : Google Scholar : PubMed/NCBI

11 

He F, Peng F, Xia X, Zhao C, Luo Q, Guan W, Li Z, Yu X and Huang F: miR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia. 57:1726–1736. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Liu D, Zhang N, Zhang J, Zhao H and Wang X: miR-410 suppresses the expression of interleukin-6 as well as renal fibrosis in the pathogenesis of lupus nephritis. Clin Exp Pharmacol Physiol. 43:616–625. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Han M, Song Y and Zhang X: Quercetin suppresses the migration and invasion in human colon cancer caco-2 cells through regulating toll-like receptor 4/nuclear factor-kappa B pathway. Pharmacogn Mag. 12 Suppl 2:S237–S244. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Chan CY, Lien CH, Lee MF and Huang CY: Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC). Biomedicine (Taipei). 6:152016. View Article : Google Scholar : PubMed/NCBI

15 

Song NR, Chung MY, Kang NJ, Seo SG, Jang TS, Lee HJ and Lee KW: Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase. Food Chem. 142:66–71. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Chen BL, Wang LT, Huang KH, Wang CC, Chiang CK and Liu SH: Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway. J Nutr Biochem. 25:1226–1234. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Erboga M, Aktas C, Erboga ZF, Donmez YB and Gurel A: Quercetin ameliorates methotrexate-induced renal damage, apoptosis and oxidative stress in rats. Ren Fail. 37:1492–1497. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Kou B, Liu W, Tang X and Kou Q: HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway. Oncol Rep. 39:101–108. 2018.PubMed/NCBI

19 

Kinashi H, Falke LL, Nguyen TQ, Bovenschen N, Aten J, Leask A, Ito Y and Goldschmeding R: Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis. Kidney Int. 92:850–863. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Ma J, Zhang L, Hao J, Li N, Tang J and Hao L: Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1. J Pharmacol Sci. 136:218–227. 2018. View Article : Google Scholar : PubMed/NCBI

21 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Shi B, Wang Y, Zhao R, Long X, Deng W and Wang Z: Bone marrow mesenchymal stem cell-derived exosomal miR-21 protects C-kit+ cardiac stem cells from oxidative injury through the PTEN/PI3K/Akt axis. PLoS One. 13:e01916162018. View Article : Google Scholar : PubMed/NCBI

23 

Gutsaeva DR, Thounaojam M, Rajpurohit S, Powell FL, Martin PM, Goei S, Duncan M and Bartoli M: STAT3-mediated activation of miR-21 is involved in down-regulation of TIMP3 and neovascularization in the ischemic retina. Oncotarget. 8:103568–103580. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Gelen V, Şengül E, Gedikli S, Gür C and Özkanlar S: Therapeutic effect of quercetin on renal function and tissue damage in the obesity induced rats. Biomed Pharmacother. 89:524–528. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Yuksel Y, Yuksel R, Yagmurca M, Haltas H, Erdamar H, Toktas M and Ozcan O: Effects of quercetin on methotrexate-induced nephrotoxicity in rats. Hum Exp Toxicol. Mar 22–2016.(Epub ahead of print). PubMed/NCBI

26 

Elbe H, Dogan Z, Taslidere E, Cetin A and Turkoz Y: Beneficial effects of quercetin on renal injury and oxidative stress caused by ciprofloxacin in rats: A histological and biochemical study. Hum Exp Toxicol. 35:276–281. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Hennino MF, Buob D, Van der Hauwaert C, Gnemmi V, Jomaa Z, Pottier N, Savary G, Drumez E, Noël C, Cauffiez C and Glowacki F: miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Sci Rep. 6:272092016. View Article : Google Scholar : PubMed/NCBI

28 

Liu XJ, Hong Q, Wang Z, Yu YY, Zou X and Xu LH: MicroRNA21 promotes interstitial fibrosis via targeting DDAH1: A potential role in renal fibrosis. Mol Cell Biochem. 411:181–189. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Wang J, Gao Y, Ma M, Li M, Zou D, Yang J, Zhu Z and Zhao X: Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem Biophys. 67:537–546. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Lan R, Geng H, Polichnowski AJ, Singha PK, Saikumar P, McEwen DG, Griffin KA, Koesters R, Weinberg JM, Bidani AK, et al: PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Renal Physiol. 302:F1210–F1223. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Kassiri Z, Oudit GY, Kandalam V, Awad A, Wang X, Ziou X, Maeda N, Herzenberg AM and Scholey JW: Loss of TIMP3 enhances interstitial nephritis and fibrosis. J Am Soc Nephrol. 20:1223–1235. 2009. View Article : Google Scholar : PubMed/NCBI

32 

McClelland AD, Herman-Edelstein M, Komers R, Jha JC, Winbanks CE, Hagiwara S, Gregorevic P, Kantharidis P and Cooper ME: miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clin Sci (Lond). 129:1237–1249. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X, Zang WQ, Li M, Ma YY, Wang T and Zhao GQ: miR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci. 58:1863–1870. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cao Y, Hu J, Sui J, Jiang L, Cong Y and Ren G: Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21. Exp Ther Med 16: 2442-2448, 2018.
APA
Cao, Y., Hu, J., Sui, J., Jiang, L., Cong, Y., & Ren, G. (2018). Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21. Experimental and Therapeutic Medicine, 16, 2442-2448. https://doi.org/10.3892/etm.2018.6489
MLA
Cao, Y., Hu, J., Sui, J., Jiang, L., Cong, Y., Ren, G."Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21". Experimental and Therapeutic Medicine 16.3 (2018): 2442-2448.
Chicago
Cao, Y., Hu, J., Sui, J., Jiang, L., Cong, Y., Ren, G."Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21". Experimental and Therapeutic Medicine 16, no. 3 (2018): 2442-2448. https://doi.org/10.3892/etm.2018.6489
Copy and paste a formatted citation
x
Spandidos Publications style
Cao Y, Hu J, Sui J, Jiang L, Cong Y and Ren G: Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21. Exp Ther Med 16: 2442-2448, 2018.
APA
Cao, Y., Hu, J., Sui, J., Jiang, L., Cong, Y., & Ren, G. (2018). Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21. Experimental and Therapeutic Medicine, 16, 2442-2448. https://doi.org/10.3892/etm.2018.6489
MLA
Cao, Y., Hu, J., Sui, J., Jiang, L., Cong, Y., Ren, G."Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21". Experimental and Therapeutic Medicine 16.3 (2018): 2442-2448.
Chicago
Cao, Y., Hu, J., Sui, J., Jiang, L., Cong, Y., Ren, G."Quercetin is able to alleviate TGF‑β‑induced fibrosis in renal tubular epithelial cells by suppressing miR‑21". Experimental and Therapeutic Medicine 16, no. 3 (2018): 2442-2448. https://doi.org/10.3892/etm.2018.6489
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team